Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial growth factor (VEGF).
This report contains market size and forecasts of Aflibercept Biosimilars in global, including the following market information:
Global Aflibercept Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aflibercept Biosimilars Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Aflibercept Biosimilars companies in 2021 (%)
The global Aflibercept Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravitreal Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aflibercept Biosimilars include Regeneron, Sanofi, Novartis, Genentech, Roche, Pfizer, Sartorius, Eli Lilly and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aflibercept Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aflibercept Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Biosimilars Market Segment Percentages, by Type, 2021 (%)
Intravitreal Injection
Intravenous Injection
Global Aflibercept Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Biosimilars Market Segment Percentages, by Application, 2021 (%)
Wet Macular Degeneration
Metastatic Colorectal Cancer
Global Aflibercept Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aflibercept Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aflibercept Biosimilars revenues share in global market, 2021 (%)
Key companies Aflibercept Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Aflibercept Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron
Sanofi
Novartis
Genentech
Roche
Pfizer
Sartorius
Eli Lilly
Bayer
Amgen
PlantForm
PharmaPraxis
Samsung Bioepis
Centus
Cadila Pharmaceuticals
Dr Reddy's
Aurobindo Pharma
Biocad
MAbxience
Hetero
Biocon
Kirin Biologics
Mylan
BeiGene
Innovent
Qilu Pharmaceutical
Hengrui Pharmaceuticals
Hisun Pharmaceutical
TOT BIOPHARM